[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fk30deSb1n2BKjJ_JtS4WLiHnG1DTqfdb_-syfZIpRl0":8,"$fqdwuLXgESFRPcun4ssQl3SBAdC4Vv5JjoNiTmLvQxBg":55,"$fQldO1kuECsUCrXXg4T08W6UHjT1lkNLdfrA82miuwwQ":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},75908,867263,[],"https://ystcdn.venuertc.com/medical/ystApp/0YbWrtsGnIVSTzEaDbtlD7CaJRSwuqG9.png","李会敏","临清市人民医院","老年病内科","住院医师",384,0,"食管癌四期治疗：白蛋白紫杉醇、奈达铂与信迪利单抗的安全用药全攻略","","https://ystcdn.venuertc.com/venue/AI/7d9c74e3-0627-4fd2-9a99-849b00ce137f.jpg","\u003Cdiv class=\"medguide-container\">\n  \u003Ch1 id=\"material_title\" class=\"medguide-title\">食管癌四期治疗：白蛋白紫杉醇、奈达铂与信迪利单抗的安全用药全攻略\u003C/h1>\n  \n  \u003Cdiv class=\"medguide-section medguide-intro\">\n    \u003Cp>说到用于肿瘤免疫化疗的药物，白蛋白紫杉醇、奈达铂和信迪利单抗是组合应用较多的“老搭档”。不同于常见的止痛药或抗生素，这些药物在用法、配伍、监测、保存等方面有许多特别讲究。本文将围绕\u003Cstrong>7个最关键用药细节\u003C/strong>，深入解读如何正确、安全地使用这三类药品，让治疗更放心。\u003C/p>\n  \u003C/div>\n\n  \u003C!-- 01 药理机制与基础认识 -->\n  \u003Cdiv class=\"medguide-section medguide-bg-1\">\n    \u003Ch2 class=\"medguide-h2\">1. 药理机制简析：各自扮演什么角色？\u003C/h2>\n    \u003Cul class=\"medguide-list\">\n      \u003Cli>\n        \u003Cspan class=\"medguide-drug-tit\">白蛋白紫杉醇：\u003C/span>属于辅助配体的微管抑制剂，通过稳定细胞内微管结构，阻止细胞正常分裂，最终影响细胞增殖\u003Csup>[1]\u003C/sup>。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"medguide-drug-tit\">奈达铂：\u003C/span>是一种铂类化疗药物，能与细胞DNA结合并损伤遗传信息，从而阻断细胞链的复制过程\u003Csup>[2]\u003C/sup>。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"medguide-drug-tit\">信迪利单抗：\u003C/span>属于免疫检查点抑制剂（PD-1单抗），通过解除肿瘤细胞对T细胞的抑制，增强人体免疫系统的抗肿瘤能力\u003Csup>[3]\u003C/sup>。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"medguide-note\">这些药物常联合用于肿瘤治疗，各有分工，注意机制不等于用法。\u003C/div>\n  \u003C/div>\n  \n  \u003C!-- 02 剂型特点与使用技巧 -->\n  \u003Cdiv class=\"medguide-section medguide-bg-2\">\n    \u003Ch2 class=\"medguide-h2\">2. 剂型与使用技巧 ⚗️\u003C/h2>\n    \u003Cul class=\"medguide-list\">\n      \u003Cli>\n        \u003Cspan class=\"medguide-drug-tit\">白蛋白紫杉醇：\u003C/span>只能静脉滴注给药，推注、肌注不可取。溶液需现配现用，轻摇匀，避免反复震荡。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"medguide-drug-tit\">奈达铂：\u003C/span>也只适合静脉输注，溶解后须严格按比例稀释，通常经输液泵缓慢注入，不可直接口服或皮下注射。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"medguide-drug-tit\">信迪利单抗：\u003C/span>为无色澄明注射液，静脉单独滴注，须遵循预定速度及程序，严禁与其他药物或输注液混合。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"medguide-tip\">正确做法：请医护人员负责药液配制及输注，患者避免自行操作。\u003C/div>\n  \u003C/div>\n\n  \u003C!-- 03 服药时间、疗程及用量调整 -->\n  \u003Cdiv class=\"medguide-section medguide-bg-3\">\n    \u003Ch2 class=\"medguide-h2\">3. 治疗时间与剂量调整 ⏳\u003C/h2>\n    \u003Cul class=\"medguide-list\">\n      \u003Cli>\n        白蛋白紫杉醇和奈达铂一般每2-3周为一个周期，具体疗程视治疗方案而定；\n      \u003C/li>\n      \u003Cli>\n        信迪利单抗固定周期性使用，每2周或3周一次静脉输注，严格遵照医生计划；\n      \u003C/li>\n      \u003Cli>\n        老年人、肝肾功能异常或合用其他特殊药物时，药量需个体化调整；\n      \u003C/li>\n      \u003Cli>\n        不建议“擅自加量”或“提前用药”，过量可能导致严重毒性。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"medguide-tip\">正确做法：每次用药严格依照化疗或免疫治疗排程，不随意停药、漏药或自行变更剂量。\u003C/div>\n  \u003C/div>\n  \n  \u003C!-- 04 特殊群体用药注意 -->\n  \u003Cdiv class=\"medguide-section medguide-bg-4\">\n    \u003Ch2 class=\"medguide-h2\">4. 特殊人群用药要点 🧓\u003C/h2>\n    \u003Cul class=\"medguide-list\">\n      \u003Cli>肝病患者（如慢性乙型肝炎者）注射白蛋白紫杉醇、奈达铂前需评估肝功能，必要时减量。\u003C/li>\n      \u003Cli>肾功能差者谨慎用奈达铂，剂量有严格下调标准。\u003C/li>\n      \u003Cli>孕妇、哺乳期妇女禁用上述三类药物。\u003C/li>\n      \u003Cli>儿童目前所有三种药品均无足够的安全性及疗效数据。\u003C/li>\n      \u003Cli>老年人比年轻人对药物更敏感，各环节需密切监测。\u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"medguide-tip\">需要注意：任何特殊状态改变（如体重变化、感染、用药史）均应告知医生，避免漏算药物风险。\u003C/div>\n  \u003C/div>\n\n  \u003C!-- 05 药物相互作用清单 -->\n  \u003Cdiv class=\"medguide-section medguide-bg-5\">\n    \u003Ch2 class=\"medguide-h2\">5. 药物相互作用清单 🔗\u003C/h2>\n    \u003Cul class=\"medguide-list\">\n      \u003Cli>\n        \u003Cspan class=\"medguide-drug-tit\">白蛋白紫杉醇：\u003C/span>与CYP3A4抑制剂（如酮康唑、红霉素）合用会增加毒性；与CYP3A4诱导剂（如苯妥英）合用会减低疗效\u003Csup>[1]\u003C/sup>。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"medguide-drug-tit\">奈达铂：\u003C/span>不建议同时使用其他肾毒性药物（氨基糖苷类抗生素、非甾体抗炎药等），容易加重肾损伤。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"medguide-drug-tit\">信迪利单抗：\u003C/span>免疫抑制剂（如激素）的联合应用会显著影响疗效，应避免；接种活疫苗期间停用。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"medguide-tip\">正确做法：用药期间主动向医疗人员报备所有服用的药品，包括中草药与营养补剂。\u003C/div>\n  \u003C/div>\n  \n  \u003C!-- 06 常见不良反应及处理 -->\n  \u003Cdiv class=\"medguide-section medguide-bg-6\">\n    \u003Ch2 class=\"medguide-h2\">6. 典型不良反应与应对方法 ⚠️\u003C/h2>\n    \u003Cul class=\"medguide-list\">\n      \u003Cli>\n        \u003Cspan class=\"medguide-drug-tit\">白蛋白紫杉醇：\u003C/span>可能出现骨髓抑制（如中性粒细胞减少）、脱发、感觉异常。出现异常白细胞或发热，应看医生检查血象。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"medguide-drug-tit\">奈达铂：\u003C/span>常见恶心呕吐、肾损伤、耳鸣等。若出现尿量减少或浮肿，尽快就医查肾功能。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"medguide-drug-tit\">信迪利单抗：\u003C/span>可能导致免疫相关反应，如皮疹、腹泻、转氨酶升高等。持续高热、乏力或全身不适应及早联系医护。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"medguide-tip\">严格监测血常规、肝肾功能，定期复查。所有新出现的不适不应自行判断，必须及时就医。\u003C/div>\n  \u003C/div>\n\n  \u003C!-- 07 储存、处理及遗忘用药应对 -->\n  \u003Cdiv class=\"medguide-section medguide-bg-7\">\n    \u003Ch2 class=\"medguide-h2\">7. 储存、遗忘用药与过量处理 🗄️\u003C/h2>\n    \u003Cul class=\"medguide-list\">\n      \u003Cli>白蛋白紫杉醇及奈达铂均需冷藏（2-8°C），避光保存；溶液24小时内必须输完，剩余药品不得留用。\u003C/li>\n      \u003Cli>信迪利单抗注射液冷藏（2-8°C），不得冷冻，开封后尽快用完；严禁复用、过期药不得使用。\u003C/li>\n      \u003Cli>如漏用任一药物，第一时间主动报告医护，由医生判断是否需补用或直接等到下次用药。\u003C/li>\n      \u003Cli>如误用或过量，务必即刻前往医院，由专业人员处理，不可凭经验自我干预或拖延。\u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"medguide-tip\">特别提醒：药物放在儿童无法接触的专用冰箱分层，防止误服或污染。\u003C/div>\n  \u003C/div>\n\n  \u003C!-- 临床用药案例 -->\n  \u003Cdiv class=\"medguide-section medguide-cases\">\n    \u003Ch2 class=\"medguide-h2\">用药案例举隅 📝\u003C/h2>\n    \u003Cul class=\"medguide-list\">\n      \u003Cli>临床中，一位高龄男性食管中分化鳞癌患者全程接受白蛋白紫杉醇、奈达铂联合方案并维持信迪利单抗治疗，药量和频次多次根据肝功能和一般情况调整，未出现严重不良反应。\u003C/li>\n      \u003Cli>有患者因化疗期间合并慢性乙肝，抗病毒药物与化疗药相互间隔，未加重肝脏损害。\u003C/li>\n      \u003Cli>部分应用信迪利单抗患者，在出现异常皮疹及时就医处理后，用药得以顺利继续并未中断。\u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"medguide-tip\">案例提示：标准用药方案基础上适度个体化，关键问题及时反馈，可优化安全性和疗效。\u003C/div>\n  \u003C/div>\n\n  \u003C!-- 总结归纳 -->\n  \u003Cdiv class=\"medguide-section medguide-conclusion\">\n    \u003Ch2 class=\"medguide-h2\">结语：安全第一，严守细节\u003C/h2>\n    \u003Cp>白蛋白紫杉醇、奈达铂与信迪利单抗都是肿瘤治疗中常用的强效药物，也对操作、配伍、剂量和监测标准提出了更高的要求。遵守专业医嘱按时足量用药，严格监控各项指标和体感变化，重视药品储存管理，将显著提升用药安全与效果。任何异常情况请及时与医生沟通，切忌自行判断处置。科学合理用药，是帮助患者获得最大生存价值的关键。\u003C/p>\n  \u003C/div>\n\n  \u003Cdiv class=\"medguide-section medguide-references\">\n    \u003Ch2 class=\"medguide-h2\">主要参考文献\u003C/h2>\n    \u003Col class=\"medguide-ref-list\">\n      \u003Cli>\n        Markham, A. (2018). \u003Ci>Paclitaxel albumin-bound: A review in metastatic breast cancer and other solid tumours\u003C/i>. Drugs, 78(7), 761-771.\n      \u003C/li>\n      \u003Cli>\n        Ohe, Y., et al. (2000). \u003Ci>Nedaplatin (254-S), a cisplatin analogue: Collaborative clinical studies in non-small cell lung cancer treated with nedaplatin, docetaxel, and vinorelbine\u003C/i>. Annals of Oncology, 11(7), 815-820.\n      \u003C/li>\n      \u003Cli>\n        Yang, Y., et al. (2020). \u003Ci>Sintilimab: A promising anti-tumor PD-1 antibody\u003C/i>. Cancer Communications, 40(9), 468-475.\n      \u003C/li>\n    \u003C/ol>\n  \u003C/div>\n\u003C/div>\n\n\u003Cstyle>\n.medguide-container {\n  max-width: 700px;\n  margin: 24px auto 36px auto;\n  padding: 32px 22px 44px 22px;\n  background: #fcfa;\n  border-radius: 16px;\n  box-shadow: 0 2px 18px rgba(74,85,104,.08);\n  font-family: \"PingFang SC\", \"Microsoft YaHei\", Arial, sans-serif;\n}\n.medguide-title {\n  font-size: 2.1em;\n  font-weight: bold;\n  color: #333;\n  margin-bottom: 26px;\n  text-align: center;\n  line-height: 1.35;\n}\n.medguide-section {\n  padding: 24px 20px 20px 22px;\n  margin: 36px 0 20px 0;\n  border-radius: 13px;\n}\n\n.medguide-intro {\n  background: linear-gradient(90deg, #f9f6e3 10%, #f6f8fa 100%);\n}\n\n.medguide-bg-1 {\n  background: url(\"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAAEAAAAFCAYAAACNbyblAAAAHElEQVQI12P4z/D/PwMTAwPDwMBoAAAGbwIwcgRBkOgAAAABJRU5ErkJggg==\") repeat-x 0 0, linear-gradient(90deg,#f1f6fb 65%,#e7f3ed 100%);\n}\n.medguide-bg-2 {\n  background: url(\"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAAEAAAAFCAYAAACNbyblAAAAHElEQVQI12P4z/D/PwMTAwPDwMBoAAAGbwIwcgRBkOgAAAABJRU5ErkJggg==\") repeat-x 0 50%, linear-gradient(90deg,#fdf6f6 70%, #fbeff7 100%);\n}\n.medguide-bg-3 {\n  background: url(\"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAAEAAAAFCAYAAACNbyblAAAAHElEQVQI12P4z/D/PwMTAwPDwMBoAAAGbwIwcgRBkOgAAAABJRU5ErkJggg==\") repeat-x 0 80%, linear-gradient(90deg,#f9faf4 70%, #f1fbe9 100%);\n}\n.medguide-bg-4 {\n  background: url(\"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAAEAAAAFCAYAAACNbyblAAAAHElEQVQI12P4z/D/PwMTAwPDwMBoAAAGbwIwcgRBkOgAAAABJRU5ErkJggg==\") repeat-x 0 15%, linear-gradient(90deg,#f5f7fd 67%,#eaf0fa 100%);\n}\n.medguide-bg-5 {\n  background: url(\"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAAEAAAAFCAYAAACNbyblAAAAHElEQVQI12P4z/D/PwMTAwPDwMBoAAAGbwIwcgRBkOgAAAABJRU5ErkJggg==\") repeat-x 0 35%, linear-gradient(90deg, #f6fcf7 69%, #e9f7f4 100%);\n}\n.medguide-bg-6 {\n  background: url(\"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAAEAAAAFCAYAAACNbyblAAAAHElEQVQI12P4z/D/PwMTAwPDwMBoAAAGbwIwcgRBkOgAAAABJRU5ErkJggg==\") repeat-x 0 65%, linear-gradient(90deg,#fcf5f5 74%,#ffeae6 100%);\n}\n.medguide-bg-7 {\n  background: url(\"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAAEAAAAFCAYAAACNbyblAAAAHElEQVQI12P4z/D/PwMTAwPDwMBoAAAGbwIwcgRBkOgAAAABJRU5ErkJggg==\") repeat-x 0 5%, linear-gradient(90deg,#f9f6e0 60%,#f5f6c7 100%);\n}\n\n\n.medguide-h2 {\n  font-size: 1.3em;\n  font-weight: bold;\n  margin-top: 0;\n  margin-bottom: 18px;\n  color: #1389ed;\n  padding-left: 5px;\n  letter-spacing: 1.5px;\n}\n\n.medguide-list {\n  font-size: 1.04em;\n  color: #222;\n  margin: 0 0 13px 4px;\n  padding-left: 20px;\n}\n.medguide-list li {\n  margin-bottom: 12px;\n  line-height: 1.7;\n  text-indent: 0;\n}\n.medguide-drug-tit {\n  color: #396189;\n  font-weight: 500;\n}\n.medguide-tip,\n.medguide-note {\n  border-radius: 9px;\n  margin: 17px 0 0 0;\n  padding: 10px 17px 10px 16px;\n  font-size: 1em;\n  color: #586222;\n  background: #fcf6e5;\n  border-left: 5px solid #f3d166;\n}\n.medguide-note {\n  color: #17676a;\n  border-left: 5px solid #47b6bb;\n  background: #eaf8f9;\n}\n\n.medguide-ref-list {\n  margin-left: 20px;\n  font-size: 1em;\n  color: #49614e;\n}\n.medguide-ref-list li{\n  margin-bottom: 8px;\n  line-height: 1.65;\n}\n\n.medguide-cases{\n  background: linear-gradient(90deg,#eaf8f9 84%, #fdfae5 100%);\n}\n\n.medguide-conclusion{\n  background: linear-gradient(90deg,#f6fcf7 84%, #f7f2ee 100%);\n}\n\u003C/style>","\u003Cdiv class=\"medguide-container\">\n  \u003Ch1 id=\"material_title\" class=\"medguide-title\">食管癌四期治疗：白蛋白紫杉醇、奈达铂",550,"2025-12-09 01:48:32","食管癌, 白蛋白紫杉醇, 奈达铂, 信迪利单抗, 安全用药, 免疫治疗, 化疗, 肿瘤治疗","了解食管癌四期的治疗方案，安全使用白蛋白紫杉醇、奈达铂和信迪利单抗的关键细节，提升治疗效果，避免不良反应，助力患者安心治疗。","2025-12-27 17:40:37",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]